SY JENNIFER (PRINCIPAL ACCOUNTING OFFICER) received a stock award from AEON BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 3/5/2026ACC: 0001104659-26-024231
Officer· PRINCIPAL ACCOUNTING OFFICER
Since Feb 2026
+1.50M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
1.50M acquired
Non-Derivative Transactions2
Class A Common Stock
Direct
Shares
+575K
Price / share
—
Trade value
—
% of position
229083.7%
2/17/2026
251.00→575.25K
Class A Common Stock
Direct
Shares
+925.92K
Price / share
—
Trade value
—
% of position
161.0%
3/4/2026
575.25K→1.50M
Total
Net shares
+1.50M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 2/17/2026 | A · Award | +575K | — | — | 229083.7% | 251.00 | 575.25K |
| Class A Common Stock Direct | 3/4/2026 | A · Award | +925.92K | — | — | 161.0% | 575.25K | 1.50M |
| Total | +1.50M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported